Highnoon Laboratories Limited (PSX:HINOON)
914.79
+9.43 (1.04%)
At close: May 13, 2025
Highnoon Laboratories Revenue
Highnoon Laboratories had revenue of 7.03B PKR in the quarter ending March 31, 2025, with 14.39% growth. This brings the company's revenue in the last twelve months to 25.51B, up 21.77% year-over-year. In the year 2024, Highnoon Laboratories had annual revenue of 24.63B with 24.60% growth.
Revenue (ttm)
25.51B
Revenue Growth
+21.77%
P/S Ratio
1.90
Revenue / Employee
10.74M
Employees
2,376
Market Cap
48.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 24.63B | 4.86B | 24.60% |
Dec 31, 2023 | 19.77B | 3.95B | 24.98% |
Dec 31, 2022 | 15.82B | 2.82B | 21.65% |
Dec 31, 2021 | 13.00B | 2.30B | 21.53% |
Dec 31, 2020 | 10.70B | 1.65B | 18.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 61.15B |
Abbott Laboratories (Pakistan) | 69.49B |
AGP Limited | 26.27B |
The Searle Company | 28.80B |
Shifa International Hospitals | 26.63B |
Citi Pharma | 13.19B |
Ferozsons Laboratories | 18.16B |
Otsuka Pakistan | 3.69B |